BARCELONA, Spain--(BUSINESS WIRE)--Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovative and ...
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation ...
Converged Digital Fraud, Anti-money Laundering and Authenticated User Impersonation Detection & Response Solution First to Deliver Pre-Crime Logistical Intelligence; State-of-the-Art Continuous ...
BioCatch, which reportedly aims to prevent financial crime by recognizing patterns in human behavior, announced an upgrade to its digital fraud- and financial crime-detection platform. BioCatch ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results